1. Home
  2. SRDX vs NPFD Comparison

SRDX vs NPFD Comparison

Compare SRDX & NPFD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SRDX
  • NPFD
  • Stock Information
  • Founded
  • SRDX 1979
  • NPFD 2021
  • Country
  • SRDX United States
  • NPFD United States
  • Employees
  • SRDX N/A
  • NPFD N/A
  • Industry
  • SRDX Medical/Dental Instruments
  • NPFD Trusts Except Educational Religious and Charitable
  • Sector
  • SRDX Health Care
  • NPFD Finance
  • Exchange
  • SRDX Nasdaq
  • NPFD Nasdaq
  • Market Cap
  • SRDX 416.1M
  • NPFD 462.7M
  • IPO Year
  • SRDX 1998
  • NPFD N/A
  • Fundamental
  • Price
  • SRDX $29.00
  • NPFD $18.99
  • Analyst Decision
  • SRDX Buy
  • NPFD
  • Analyst Count
  • SRDX 2
  • NPFD 0
  • Target Price
  • SRDX $43.00
  • NPFD N/A
  • AVG Volume (30 Days)
  • SRDX 69.7K
  • NPFD 64.7K
  • Earning Date
  • SRDX 07-30-2025
  • NPFD 01-01-0001
  • Dividend Yield
  • SRDX N/A
  • NPFD 6.28%
  • EPS Growth
  • SRDX N/A
  • NPFD N/A
  • EPS
  • SRDX N/A
  • NPFD N/A
  • Revenue
  • SRDX $121,575,000.00
  • NPFD N/A
  • Revenue This Year
  • SRDX N/A
  • NPFD N/A
  • Revenue Next Year
  • SRDX $3.70
  • NPFD N/A
  • P/E Ratio
  • SRDX N/A
  • NPFD N/A
  • Revenue Growth
  • SRDX N/A
  • NPFD N/A
  • 52 Week Low
  • SRDX $26.00
  • NPFD $14.50
  • 52 Week High
  • SRDX $42.44
  • NPFD $18.07
  • Technical
  • Relative Strength Index (RSI)
  • SRDX 48.86
  • NPFD 54.58
  • Support Level
  • SRDX $28.67
  • NPFD $18.74
  • Resistance Level
  • SRDX $29.87
  • NPFD $19.18
  • Average True Range (ATR)
  • SRDX 0.75
  • NPFD 0.19
  • MACD
  • SRDX -0.05
  • NPFD -0.02
  • Stochastic Oscillator
  • SRDX 26.60
  • NPFD 55.26

About SRDX Surmodics Inc.

Surmodics Inc is a provider of performance coating technologies for intravascular medical devices and chemical and biological components for in vitro diagnostic (IVD) immunoassay tests and microarrays. The company's reportable segments are; Medical Device and In Vitro Diagnostics. Maximum revenue for the company is derived from its Medical Device segment which is involved in the manufacturing and licensing of performance coatings, including surface modification coating technologies and drug-delivery coating technologies. This segment also manufactures vascular intervention medical devices, including drug-coated balloons, mechanical thrombectomy devices, and radial access balloon catheters and guide sheaths. Geographically, the company derives key revenue from its domestic market.

About NPFD Nuveen Variable Rate Preferred & Income Fund

Nuveen Variable Rate Preferred&Income is a newly organized, diversified, closed-end management investment company. The Fund's investment objective is to seek to provide a high level of current income and total return.

Share on Social Networks: